Literature DB >> 10456340

Risk factors associated with the failure of a venous leg ulcer to heal.

D J Margolis1, J A Berlin, B L Strom.   

Abstract

BACKGROUND: Venous leg ulcers afflict a significant portion of the population. The most popular form of therapy for venous leg ulcers is a compression bandage (eg, Unna boot), a therapy that is frequently unsuccessful.
OBJECTIVE: To describe risk factors associated with the failure of a wound to heal when treated with a limb-compression bandage for 24 weeks.
DESIGN: A retrospective cohort study.
SETTING: Single-center outpatient specialty clinic at an academic medical center. PARTICIPANTS: Two hundred sixty consecutive patients with chronic venous leg ulcers. MAIN OUTCOME MEASURE: The magnitude of the effect of a given risk factor on the probability that a wound will heal within 24 weeks of care.
RESULTS: Based on an assessment of leg wounds during initial office visits, we observed that the failure of a wound to heal within 24 weeks was significantly associated with larger wound area, measured in square centimeters (odds ratio [OR], 1.19; 95% confidence interval [CI], 1.11-1.27), duration of the wound in months (OR, 1.09; 95% CI, 1.04-1.16), history of venous ligation or venous stripping (OR, 4.58; 95% CI, 1.84-11.36), history of hip or knee replacement surgery (OR, 3.52; 95% CI, 1.12-11.08), ankle brachial index of less than 0.80 (OR, 3.52; 95% CI, 1.12-11.08), and the presence of fibrin on more than 50% of the wound surface (OR, 3.42; 95% CI, 1.38-8.45).
CONCLUSIONS: Several risk factors are associated with the failure of a patient's venous leg ulcer to heal while using limb-compression therapy. It is prudent to consider these factors when referring a patient to a wound care subspecialists or for alternative therapies.

Entities:  

Mesh:

Year:  1999        PMID: 10456340     DOI: 10.1001/archderm.135.8.920

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  28 in total

Review 1.  Wound chronicity and fibroblast senescence--implications for treatment.

Authors:  Keith G Harding; Keith Moore; Tania J Phillips
Journal:  Int Wound J       Date:  2005-12       Impact factor: 3.315

2.  Predicting complex acute wound healing in patients from a wound expertise centre registry: a prognostic study.

Authors:  Dirk T Ubbink; Robert Lindeboom; Anne M Eskes; Huub Brull; Dink A Legemate; Hester Vermeulen
Journal:  Int Wound J       Date:  2013-09-06       Impact factor: 3.315

3.  Evaluation of the use of prognostic information for the care of individuals with venous leg ulcers or diabetic neuropathic foot ulcers.

Authors:  Shanu K Kurd; Ole J Hoffstad; Warren B Bilker; David J Margolis
Journal:  Wound Repair Regen       Date:  2009 May-Jun       Impact factor: 3.617

4.  A single-arm trial indirect comparison investigation: a proof-of-concept method to predict venous leg ulcer healing time for a new acellular synthetic matrix matched to standard care control.

Authors:  Ronald Shannon; Andrea Nelson
Journal:  Int Wound J       Date:  2016-11-20       Impact factor: 3.315

Review 5.  Preventing venous ulcer recurrence: a review.

Authors:  Kathryn R Vowden; Peter Vowden
Journal:  Int Wound J       Date:  2006-03       Impact factor: 3.315

6.  A prospective, multicentre, randomised controlled study of human fibroblast-derived dermal substitute (Dermagraft) in patients with venous leg ulcers.

Authors:  Keith Harding; Michael Sumner; Matthew Cardinal
Journal:  Int Wound J       Date:  2013-04       Impact factor: 3.315

7.  The Use of a Pure Native Collagen Dressing for Wound Bed Preparation Prior to Use of a Living Bi-layered Skin Substitute.

Authors:  Naz Wahab; Martha Roman; Debashish Chakravarthy; Tammy Luttrell
Journal:  J Am Coll Clin Wound Spec       Date:  2015-04-15

Review 8.  Protease activity as a prognostic factor for wound healing in venous leg ulcers.

Authors:  Maggie J Westby; Jo C Dumville; Nikki Stubbs; Gill Norman; Jason Kf Wong; Nicky Cullum; Richard D Riley
Journal:  Cochrane Database Syst Rev       Date:  2018-09-01

9.  Clinical evaluation of the efficacy and safety of a medical device in various forms containing Triticum vulgare for the treatment of venous leg ulcers - a randomized pilot study.

Authors:  Marco Romanelli; Michela Macchia; Salvatore Panduri; Battistino Paggi; Giorgio Saponati; Valentina Dini
Journal:  Drug Des Devel Ther       Date:  2015-05-27       Impact factor: 4.162

10.  Epidemiology and Genetics of Venous Thromboembolism and Chronic Venous Disease.

Authors:  Richard A Baylis; Nicholas L Smith; Derek Klarin; Eri Fukaya
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.